

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 5mg | 360 pills | A$1.33 | A$638.21 A$478.65 Best Price | |
| 5mg | 270 pills | A$1.48 | A$534.79 A$401.09 | |
| 5mg | 180 pills | A$1.66 | A$398.87 A$299.15 | |
| 5mg | 120 pills | A$1.95 | A$313.18 A$234.88 | |
| 5mg | 90 pills | A$1.99 | A$239.31 A$179.48 | |
| 5mg | 60 pills | A$2.22 | A$177.26 A$132.94 | |
| 5mg | 30 pills | A$2.81 | A$112.25 A$84.19 | |
| 10mg | 360 pills | A$2.04 | A$978.01 A$733.51 | |
| 10mg | 270 pills | A$2.15 | A$774.13 A$580.60 | |
| 10mg | 180 pills | A$2.24 | A$537.74 A$403.31 | |
| 10mg | 120 pills | A$2.37 | A$378.18 A$283.64 | |
| 10mg | 90 pills | A$2.53 | A$304.31 A$228.24 | |
| 10mg | 60 pills | A$2.70 | A$215.67 A$161.75 | |
| 10mg | 30 pills | A$3.17 | A$127.03 A$95.27 | |
| 20mg | 360 pills | A$3.15 | A$1,509.87 A$1,132.40 Popular | |
| 20mg | 270 pills | A$3.30 | A$1,187.80 A$890.85 | |
| 20mg | 180 pills | A$3.48 | A$836.18 A$627.13 | |
| 20mg | 120 pills | A$3.63 | A$582.07 A$436.55 | |
| 20mg | 90 pills | A$3.90 | A$466.83 A$350.12 | |
| 20mg | 60 pills | A$4.17 | A$333.86 A$250.40 | |
| 20mg | 30 pills | A$4.45 | A$177.26 A$132.94 |
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) and the S-enantiomer of citalopram. By selectively inhibiting the serotonin transporter, it increases synaptic serotonin concentrations in CNS pathways involved in mood and anxiety regulation and is used primarily for major depressive disorder and generalized anxiety disorder.
Escitalopram belongs to the class of medicines known as SSRIs. Its pharmacologic action derives from high affinity blockade of the serotonin transporter (SERT), producing a net increase in serotonin signaling within mood and affective circuits. The drug exists as the pure S-enantiomer of citalopram, which contributes to its clinical profile and tolerability relative to mixed enantiomer preparations.
Pharmacokinetically, escitalopram is absorbed with good oral bioavailability and undergoes hepatic metabolism to active and inactive metabolites. The elimination half-life is approximately 27β32 hours, supporting once-daily dosing in most adults. Dose adjustments may be necessary for hepatic impairment and in the setting of concomitant medications that influence cytochrome P450 enzymes, particularly CYP2C19, CYP3A4, and CYP2D6 pathways.
Escitalopram is approved for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in adults. In clinical practice, it is used to alleviate depressive symptoms and excessive anxiety, with benefits typically emerging after several weeks of therapy. The therapeutic regimen is typically individualized based on symptom severity, past response, and tolerability.
Beyond these primary indications, escitalopram is sometimes prescribed off-label for related anxiety disorders or comorbid depressive symptoms in adults, and may be considered in select adolescent patients under specialist supervision. In all populations, treatment decisions should account for comorbid conditions, prior antidepressant experience, and risk of adverse effects or interactions with other medications.
Recommended adult dosing commonly starts at 10 mg once daily, with the option to increase to 20 mg daily after at least one week if response is inadequate and tolerability is good. Dose adjustments should be guided by clinical response and adverse effects. Lower starting doses are advised for elderly patients or those with hepatic impairment, with careful monitoring for mood changes and tolerability.
Administration is usually once daily. Most patients tolerate morning dosing, as escitalopram can cause insomnia in some individuals; however, if sleep disturbance occurs, taking the dose in the early evening may be considered after discussion with a clinician. The capsule or tablets may be taken with or without food, depending on patient preference; there is no required relation to meals for absorption.
If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose. Do not double the next dose to compensate for a missed one. If discontinuation is planned or unavoidable, a gradual taper over at least one to two weeks is recommended to reduce the risk of discontinuation symptoms such as dizziness, irritability, or flu-like sensations. Do not stop abruptly unless directed by a clinician, especially after several weeks of therapy or at higher doses.
Storage should be at room temperature, protected from moisture and heat. Keep escitalopram out of reach of children and pets. Do not use beyond the labeled expiry date. If a dose is accidentally consumed in excess, seek medical advice promptly or contact a poison control center for guidance.
Common adverse effects in the early weeks of treatment include nausea, dry mouth, fatigue, increased sleepiness or trouble sleeping, and mild dizziness. Some individuals may notice reduced sexual desire or difficulty reaching orgasm. These effects are usually temporary or diminish with continued therapy, though persistent symptoms should be discussed with a clinician.
Less common but important concerns include agitation, anxiety, or restlessness, as well as sweating and changes in appetite. Hyponatremia, particularly in older adults or those on diuretic therapy, can present with confusion, weakness, or seizures and requires medical evaluation. A small number of patients may experience an increased risk of bleeding when taking escitalopram with nonsteroidal anti-inflammatory drugs or anticoagulants. Serotonin syndrome, a rare but potentially life-threatening reaction, can occur when escitalopram is combined with other serotonergic drugs and is characterized by agitation, fever, rapid heart rate, tremor, or muscle rigidity. If there is sudden fever, confusion, severe stiffness, or rapidly worsening symptoms, seek urgent medical care.
Discontinuation symptoms can occur if the drug is stopped abruptly, including dizziness, sensory disturbances, flu-like symptoms, and mood changes. Gradual tapering under medical guidance reduces these risks. In rare instances, escitalopram can trigger mania in individuals with underlying bipolar tendencies. Monitor mood changes and report any signs of mania or hypomania promptly.
Seek medical advice promptly if there is worsening depression or new thoughts of self-harm, especially in the initial weeks of treatment or after dose changes. Immediate medical attention is warranted for signs of a severe allergic reaction (rash, swelling, or trouble breathing) or for symptoms suggestive of serotonin syndrome. If unusual bleeding, severe headaches, confusion, or seizure-like activity occurs, contact a clinician without delay.
Discuss with a healthcare professional before starting escitalopram if you are pregnant, planning pregnancy, or breastfeeding, as there may be considerations for fetal development or neonatal adaptation syndrome. Inform your clinician about all concomitant medications, including over-the-counter drugs and herbal supplements, to assess potential interactionsβparticularly other serotonergic agents, NSAIDs, anticoagulants, or medications known to affect heart rhythm. Regular follow-up is advised to monitor therapeutic response and adverse effects, and to reassess treatment needs over time.
14β21 days. Free from A$285.95 .
5β9 days. A$42.89
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
